Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries

Clinical Cardiology

Volumn 37, Issue 8, 2014, Pages 462-467

  Ong, Peter ^a   Athanasiadis, Anastasios ^a   Hill, Stephan ^a   Schäufele, Tim ^a   Mahrholdt, Heiko ^a   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PROVOCATION TEST; ST SEGMENT DEPRESSION; VASOCONSTRICTION; VASOMOTOR REFLEX; AGED; COMPLICATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ELECTROCARDIOGRAPHY; EXERCISE TEST; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ACETYLCHOLINE; AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VASODILATOR AGENTS;

EID: 84906343071     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22282     Document Type: Article

References (24)

1. Ong P, Athanasiadis A, Borgulya G, et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: the ACOVA Study (Abnormal Coronary Vasomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012; 59: 655-662.
2. Matsuzawa Y, Sugiyama S, Sugamura K, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol. 2010; 55: 1688-1696.
3. Ong P, Sivanathan R, Borgulya G, et al. Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X). Cardiovasc Drugs Ther. 2012; 26: 239-244.
4. Reis SE, Holubkov R, Conrad Smith AJ, et al. WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001; 141: 735-741.
5. Lanza GA,. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007; 93: 159-166.
6. Kaski JC,. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation. 2004; 109: 568-572.
7. Granger DN, Rodrigues SF, Yildirim A, et al. Microvascular responses to cardiovascular risk factors. Microcirculation. 2010; 17: 192-205.
8. Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J. 2009; 30: 1837-1843.
9. Camici PG, Crea F,. Coronary microvascular dysfunction. N Engl J Med. 2007; 356: 830-840.
10. Ong P, Athanasiadis A, Mahrholdt H, et al. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol. 2012; 101: 673-681.
11. Maseri A, Crea F, Kaski JC, et al. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991; 17: 499-506.
12. Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res. 2008; 80: 165-174.
13. Lanza GA, Camici PG, Galiuto L, et al. Gruppo di Studio di Fisiopatologia Coronarica e Microcircolazione, Società Italiana di Cardiologia. Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med. 2013; 14: 1-18.
14. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002; 346: 1948-1953.
15. Yilmaz A, Athanasiadis A, Mahrholdt H, et al. Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing. Heart. 2010; 96: 372-379.
16. Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007; 99: 1378-1383.
17. Cassar A, Chareonthaitawee P, Rihal CS, et al. Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease. Circ Cardiovasc Interv. 2009; 2: 237-244.
18. Pauly DF, Johnson BD, Anderson RD, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J. 2011; 162: 678-684.
19. Kayikcioglu M, Payzin S, Yavuzgil O, et al. Benefits of statin treatment in cardiac syndrome X. Eur Heart J. 2003; 24: 1999-2005.
20. Ozçelik F, Altun A, Ozbay G,. Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X. Clin Cardiol. 1999; 22: 361-365.
21. Johnson BD, Shaw LJ, Pepine CJ, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Eur Heart J. 2006; 27: 1408-1415.
22. Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012; 33: 734-744.
23. Jespersen L, Abildstrøm SZ, Hvelplund A, et al. Symptoms of angina pectoris increase the probability of disability pension and premature exit from the workforce even in the absence of obstructive coronary artery disease. Eur Heart J. 2013; 34: 3294-3303.
24. Dhawan SS, Corban MT, Nanjundappa RA, et al. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis. 2012; 223: 384-388.